Caribou Biosciences, Inc.CRBUNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank17
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-130.70M
↓ 45% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-90.38M
Historical baseline
PeriodValueYoY Change
TTM$-130.70M+19.7%
2024$-162.69M-44.6%
2023$-112.53M-17.6%
2022$-95.71M-45.9%
2021$-65.61M-86.4%
2020$-35.21M-16.5%
2019$-30.21M-